Design Pharmaceuticals Inc.
Boundless GPCR drug discovery
3 employees · est. 2018 · Cambridge, United States
Domain Therapeutics
#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression
88 employees · est. 2008 · Illkirch-graffenstaden, Fran...
Domain Therapeutics is the older company (2018 vs 2008); Domain Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Design Pharmaceuticals Inc. | Domain Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2008 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Illkirch-graffenstaden, France |
| Employees | ||
| Employees | 3 | 88 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Seed | Grant |
| Total Funding | ||
| Total Funding | $5.00M | $90.04M |
| Funding Rounds | ||
| Funding Rounds | 1 | 10 |
| Services | ||
| Services | Interior design consultations, Product lines in textiles and lighting, Public speaking and lectures, Brand representation and ambassadorship, Digital home management solutions, Virtual design consultations | Not tracked yet |
| Target Customers | ||
| Target Customers | Homeowners, Interior design enthusiasts, Furniture and home product retailers, Design studios, Event organizers for speaking engagements | Not tracked yet |
| Taxonomy | ||
| Taxonomy | GPCR Drug Discovery, Ultra-high Throughput Bioscience, Therapeutic Market, Cell-based Screening Platform, Drug Development, Microfluidics, Pharmaceutical Research, NGS Technology, Therapeutic Innovation, Biologics Libraries, Compound Screening, Drug Function Assays, Targeted Therapies, Innovative Drug Discovery | Biopharma, Biotech, Drug Discovery, Immunooncology, GPCR, Immunosuppression, Clinical-stage Biopharmaceutical, Treg-depleting, PAR2 Negative Allosteric Modulator, EP4 Receptor Antagonist, A2aR/A2b Receptor Antagonist, Small Molecules, Innovative Technology Platform, Strasbourg, France, GPCR Ligands |
| Website | ||
| Website | designpharmaceuticals.com | domaintherapeutics.com |
About Design Pharmaceuticals Inc.
Design Pharmaceuticals Inc., founded in 2018, is carving out a niche in the Biotechnology, Health Care, and Pharmaceutical sectors with its innovative approach to GPCR drug discovery. With the slogan "Boundless GPCR drug discovery", the company aims to revolutionize the market by dramatically accele...
About Domain Therapeutics
Domain Therapeutics is a clinical-stage global biopharmaceutical company founded in 2001, headquartered in France. The company is focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), which are crucial in drug discovery. Domain Therapeutics aims to unlock ne...
We will tell you when either one moves
BounceWatch watches Design Pharmaceuticals Inc. and Domain Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Design Pharmaceuticals... and Domain Therapeutics — by email.
Frequently Asked Questions
Compare Design Pharmaceuticals Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Design Pharmaceuticals Inc. on 12 Sep 2024, and Domain Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.